167 related articles for article (PubMed ID: 19188040)
1. The outcomes after surgical resection in pancreatic endocrine tumors: an institutional experience.
You DD; Lee HG; Paik KY; Heo JS; Choi SH; Choi DW
Eur J Surg Oncol; 2009 Jul; 35(7):728-33. PubMed ID: 19188040
[TBL] [Abstract][Full Text] [Related]
2. Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems.
Pomianowska E; Gladhaug IP; Grzyb K; Røsok BI; Edwin B; Bergestuen DS; Mathisen O
Scand J Gastroenterol; 2010 Aug; 45(7-8):971-9. PubMed ID: 20441530
[TBL] [Abstract][Full Text] [Related]
3. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
4. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
Bahra M; Jacob D; Pascher A; Plockinger U; Kristiansen G; Neuhaus P; Langrehr JM
J Gastroenterol Hepatol; 2007 Jun; 22(6):930-5. PubMed ID: 17489964
[TBL] [Abstract][Full Text] [Related]
5. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.
Bilimoria KY; Talamonti MS; Tomlinson JS; Stewart AK; Winchester DP; Ko CY; Bentrem DJ
Ann Surg; 2008 Mar; 247(3):490-500. PubMed ID: 18376195
[TBL] [Abstract][Full Text] [Related]
6. Extended surgery for advanced pancreatic endocrine tumours.
Kleine M; Schrem H; Vondran FW; Krech T; Klempnauer J; Bektas H
Br J Surg; 2012 Jan; 99(1):88-94. PubMed ID: 22135173
[TBL] [Abstract][Full Text] [Related]
7. Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?
Maire F; Hammel P; Kianmanesh R; Hentic O; Couvelard A; Rebours V; Zappa M; Raymond E; Sauvanet A; Louvet C; Lévy P; Belghiti J; Ruszniewski P
Surgery; 2009 Jan; 145(1):69-75. PubMed ID: 19081477
[TBL] [Abstract][Full Text] [Related]
8. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
Teh SH; Deveney C; Sheppard BC
Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
[TBL] [Abstract][Full Text] [Related]
9. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of pancreatic endocrine neoplasms.
Gomez-Rivera F; Stewart AE; Arnoletti JP; Vickers S; Bland KI; Heslin MJ
Am J Surg; 2007 Apr; 193(4):460-5. PubMed ID: 17368289
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas.
Fischer L; Kleeff J; Esposito I; Hinz U; Zimmermann A; Friess H; Büchler MW
Br J Surg; 2008 May; 95(5):627-35. PubMed ID: 18306152
[TBL] [Abstract][Full Text] [Related]
12. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF
Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464
[TBL] [Abstract][Full Text] [Related]
14. Surgical management for carcinoma of the gallbladder: a single-institution experience in 25 years.
Liang JW; Dong SX; Zhou ZX; Tian YT; Zhao DB; Wang CF; Zhao P
Chin Med J (Engl); 2008 Oct; 121(19):1900-5. PubMed ID: 19080121
[TBL] [Abstract][Full Text] [Related]
15. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms.
Cho CS; Labow DM; Tang L; Klimstra DS; Loeffler AG; Leverson GE; Fong Y; Jarnagin WR; D'Angelica MI; Weber SM; Blumgart LH; Dematteo RP
Cancer; 2008 Jul; 113(1):126-34. PubMed ID: 18457323
[TBL] [Abstract][Full Text] [Related]
16. Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience.
Schurr PG; Strate T; Rese K; Kaifi JT; Reichelt U; Petri S; Kleinhans H; Yekebas EF; Izbicki JR
Ann Surg; 2007 Feb; 245(2):273-81. PubMed ID: 17245182
[TBL] [Abstract][Full Text] [Related]
17. Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas.
Bettini R; Mantovani W; Boninsegna L; Crippa S; Capelli P; Bassi C; Scarpa A; Pederzoli P; Falconi M
Dig Liver Dis; 2009 Jan; 41(1):49-55. PubMed ID: 18463008
[TBL] [Abstract][Full Text] [Related]
18. [Neuroendocrine tumors of the gastroenteropancreatic system--reevaluation using the Capella classification].
Brüwer M; Pahlov-Nejad T; Herbst H; Senninger N; Schürmann G
Zentralbl Chir; 2003 Aug; 128(8):656-62. PubMed ID: 12931261
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
[TBL] [Abstract][Full Text] [Related]
20. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
